‪Tuberculosis‬ INDIA: Fact Check

Tuberculosis INDIA: Fact Check

 

Tuberculosis INDIA: Fact Check

 

Did you know?
1. At least 2 deaths occur every 3 mins from TB in India and these are PREVENTABLE
2. A single patient with TB can affect 10 or more people in a year
3. National Tuberculosis Institute in Bangalore and Tuberculosis Research Centre in Chennai have a distinguished track record of breakthrough research in TB for the entire globe
4. Nearly 100,000 cases of serious multi-drug resistant TB (MDR-TB) occur in the country every year
5. 1 in 6 deaths in the age group 15-49 is due to TB
6. During the 2012-17 period – the RNTCP II intends to evaluate 48 million people for TB
7. If the program is implemented successfully – it will result in reducing the TB incidence by 40% and MDR-TB by 50% which translates to 750,000 lives saved, 1.7 million lives over 15 years!!!

 

‪ActivHealthTips‬
• Early and timely identification of all TB cases including MDR-TB is a critical step in stopping the transmission of TB and thus is effective TB control
• Identification of people with more than 2 weeks of continued cough and timely referral to assess chest symptoms, sputum smear microscopy
• Smear-positive patients are referred for Anti-TB treatment and smear-negative patients go through a clinical diagnostic pathway
• Extra-pulmonary TB is largely detected based on strong clinical suspicion and frequently referred to tertiary healthcare centres or medical colleges
• Clinical high-risk groups include patients living with HIV/AIDS, contacts of TB cases, diabetics, smokers, malnourished, alcoholic and geriatric populations
• Slum dwellers, migrant population, patients with occupational risk factors (such as mining) and tribal groups are also identified as socioeconomic risk group

 

Current TB Research & Medical Updates
• Sputum-smear Microscopy: The LED Fluoroscent microscopes (LED-FM) have higher sensitivity, higher throughput (less time per slide), lower maintenance and better battery operation – which is ideal for centres with high TB suspect workload and/or inconsistent power supply
• MDR-TB: Automated nucleic acid amplification test provides a diagnosis of TB and rifampicin resistance within 2 hours. A further improvised version cartridge based automated nucleic acid amplification systems (CB-NAAT) for the diagnosis of drug resistant TB is being evaluated for initial TB diagnostic in PLHIV, paediatric TB diagnosis, extrapulmonary TB diagnosis. The ‪#‎Government‬ of India launched 500 CB-NAAT machines which will now provide results within 2 hours
• MDR-TB: A new Anti-TB drug – ‪#‎Bedaquilline‬ was launched on World TB Day for patients suffering from Drug Resistant TB
• HIV infected TB: National Aids Control Organisation (NACO) recommends that ‘ART be initiated as soon as possible, within 2 weeks to 2 months of initiation of anti-TB treatment for all HIV infected TB patients. Current evidence shows that the mortality risk is reduced by 64-95% by use of concurrent ART. A third line ART programme for people living with HIV was launched by the government which is provided free of cost to patients. The life-saving third line ART costs nearly INR 1.18 Lakh rupees per patient per year

shareShare on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *